MDxHealth's H1 Revenues Double | GenomeWeb

NEW YORK (GenomeWeb News) – MDxHealth today said that its revenues for the first half of 2013 doubled year over year.

For the six months ended June 30, total revenues reached €3.0 ($4.0 million), up from €1.5 million in the first half of 2012. All revenues came from commercial operations as MDxHealth received no government grants, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.